Fairview Care Center | |
702 10th Avenue Northwest, Po Box 10, Dodge Center, Minnesota 55927 | |
(507) 374-2578 | |
Name | Fairview Care Center |
---|---|
Location | 702 10th Avenue Northwest, Po Box 10, Dodge Center, Minnesota |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 55 |
Occupancy Rate | 69.82% |
Medicare ID (CCN) | 245344 |
Legal Business Name | County Of Dodge |
Ownership Type | Government - County |
NPI Number | 1689783987 |
Organization Name | COUNTY OF DODGE |
Doing Business As | FAIRVIEW CARE CENTER |
Address | 702 10th Ave Nw, Dodge Center, MN 55927 |
Phone Number | 507-374-2578 |
News Archive
Results of the largest U.S. outpatient heart failure clinical study show that implementation of a process improvement program significantly improved adherence to evidence-based, guideline-recommended cardiac resynchronization therapy (CRT), implantable cardioverter-defibrillator (ICD) and drug therapy.
Novartis announced today that the Committee for Medicinal Products for Human Use has recommended the approval of Cosentyx (secukinumab) in Europe to treat ankylosing spondylitis (AS) and psoriatic arthritis (PsA) patients.
Researchers from the University of Washington and the Fred Hutchinson Cancer Research Centre in Seattle have placed mice in a state of near suspended animation, raising the possibility that in future hibernation could be induced in humans.
Controversy has long existed over the benefit of the prostate specific antigen (PSA) test used to screen for the presence of prostate cancer, and there has been little study to document the risk profile of men who have a PSA level at or below what is considered 'normal.' New research published in the latest edition of Archives of Internal Medicine (Vol. 170, No. 14) by a team of investigators at The Cancer Institute of New Jersey (CINJ), further explores this population. The findings show that most men with prostate cancer who tested below the normal PSA level and had low-risk disease nevertheless underwent aggressive treatment. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Results of the largest U.S. outpatient heart failure clinical study show that implementation of a process improvement program significantly improved adherence to evidence-based, guideline-recommended cardiac resynchronization therapy (CRT), implantable cardioverter-defibrillator (ICD) and drug therapy.
Novartis announced today that the Committee for Medicinal Products for Human Use has recommended the approval of Cosentyx (secukinumab) in Europe to treat ankylosing spondylitis (AS) and psoriatic arthritis (PsA) patients.
Researchers from the University of Washington and the Fred Hutchinson Cancer Research Centre in Seattle have placed mice in a state of near suspended animation, raising the possibility that in future hibernation could be induced in humans.
Controversy has long existed over the benefit of the prostate specific antigen (PSA) test used to screen for the presence of prostate cancer, and there has been little study to document the risk profile of men who have a PSA level at or below what is considered 'normal.' New research published in the latest edition of Archives of Internal Medicine (Vol. 170, No. 14) by a team of investigators at The Cancer Institute of New Jersey (CINJ), further explores this population. The findings show that most men with prostate cancer who tested below the normal PSA level and had low-risk disease nevertheless underwent aggressive treatment. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 16.67 | 14.46 |
Percentage of long-stay residents who lose too much weight | 8 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 58.9 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 4.15 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.96 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 4.35 | 5.05 |
Percentage of long-stay residents who were physically restrained | 2.1 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 9.79 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 88.11 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 11.35 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 84.04 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 6.15 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 31.84 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 12.78 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 2.86 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.63 | 95.98 |
Percentage of short-stay residents who made improvements in function | 91.85 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 91.38 | 82.93 |
News Archive
Results of the largest U.S. outpatient heart failure clinical study show that implementation of a process improvement program significantly improved adherence to evidence-based, guideline-recommended cardiac resynchronization therapy (CRT), implantable cardioverter-defibrillator (ICD) and drug therapy.
Novartis announced today that the Committee for Medicinal Products for Human Use has recommended the approval of Cosentyx (secukinumab) in Europe to treat ankylosing spondylitis (AS) and psoriatic arthritis (PsA) patients.
Researchers from the University of Washington and the Fred Hutchinson Cancer Research Centre in Seattle have placed mice in a state of near suspended animation, raising the possibility that in future hibernation could be induced in humans.
Controversy has long existed over the benefit of the prostate specific antigen (PSA) test used to screen for the presence of prostate cancer, and there has been little study to document the risk profile of men who have a PSA level at or below what is considered 'normal.' New research published in the latest edition of Archives of Internal Medicine (Vol. 170, No. 14) by a team of investigators at The Cancer Institute of New Jersey (CINJ), further explores this population. The findings show that most men with prostate cancer who tested below the normal PSA level and had low-risk disease nevertheless underwent aggressive treatment. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.
› Verified 2 days ago
Fairview Care Center Location: 702 10th Avenue Northwest, Po Box 10, Dodge Center, Minnesota 55927 Phone: (507) 374-2578 |